These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2425846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
    Borsotto M, Barhanin J, Norman RI, Lazdunski M.
    Biochem Biophys Res Commun; 1984 Aug 16; 122(3):1357-66. PubMed ID: 6089781
    [Abstract] [Full Text] [Related]

  • 3. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U, Pongs O.
    Eur J Biochem; 1989 May 01; 181(2):467-73. PubMed ID: 2540975
    [Abstract] [Full Text] [Related]

  • 4. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M, Barhanin J, Borsotto M, Fosset M, Galizzi JP, Renaud JF, Romey G, Schmid A.
    J Cardiovasc Pharmacol; 1986 May 01; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [Abstract] [Full Text] [Related]

  • 5. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ, Tuana BS.
    Can J Physiol Pharmacol; 1990 Nov 01; 68(11):1389-95. PubMed ID: 1962734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity of calcium channels from a purified dihydropyridine receptor preparation.
    Talvenheimo JA, Worley JF, Nelson MT.
    Biophys J; 1987 Nov 01; 52(5):891-9. PubMed ID: 2447966
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Calcium channel activity in a purified dihydropyridine-receptor preparation of skeletal muscle.
    Smith JS, McKenna EJ, Ma JJ, Vilven J, Vaghy PL, Schwartz A, Coronado R.
    Biochemistry; 1987 Nov 03; 26(22):7182-8. PubMed ID: 2447943
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of molecular properties of the voltage-sensitive Ca2+ channel from longitudinal smooth muscle of rabbit ileum with the channel purified from transverse tubules of rabbit skeletal muscle.
    Ice KS, Takahashi M, Curtis BM, Catterall WA.
    Circ Res; 1987 Oct 03; 61(4 Pt 2):I24-9. PubMed ID: 2443272
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC, Stafford GA, Henstenberg JD, Sharp GW, Weiland GA.
    J Pharmacol Exp Ther; 1991 Aug 03; 258(2):652-62. PubMed ID: 1713965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.